These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 27714968)
1. Antiamyloidogenic Activity of Aβ42-Binding Peptoid in Modulating Amyloid Oligomerization. Zhao Z; Zhu L; Li H; Cheng P; Peng J; Yin Y; Yang Y; Wang C; Hu Z; Yang Y Small; 2017 Jan; 13(1):. PubMed ID: 27714968 [TBL] [Abstract][Full Text] [Related]
2. Aβ42-binding peptoids as amyloid aggregation inhibitors and detection ligands. Luo Y; Vali S; Sun S; Chen X; Liang X; Drozhzhina T; Popugaeva E; Bezprozvanny I ACS Chem Neurosci; 2013 Jun; 4(6):952-62. PubMed ID: 23427915 [TBL] [Abstract][Full Text] [Related]
3. Modulating amyloid-β aggregation: The effects of peptoid side chain placement and chirality. Turner JP; Chastain SE; Park D; Moss MA; Servoss SL Bioorg Med Chem; 2017 Jan; 25(1):20-26. PubMed ID: 27776890 [TBL] [Abstract][Full Text] [Related]
4. Genesis of Neuroprotective Peptoid from Aβ30-34 Inhibits Aβ Aggregation and AChE Activity. Pradhan K; Das G; Mondal P; Khan J; Barman S; Ghosh S ACS Chem Neurosci; 2018 Dec; 9(12):2929-2940. PubMed ID: 30036464 [TBL] [Abstract][Full Text] [Related]
5. Rationally Designed Peptoid Inhibitors of Amyloid-β Oligomerization. Waugh ML; Wolf LM; Moore KA; Servoss SL; Moss MA Chembiochem; 2024 Jul; 25(13):e202400060. PubMed ID: 38715149 [TBL] [Abstract][Full Text] [Related]
6. Synthesized Aβ42 Caused Intracellular Oxidative Damage, Leading to Cell Death, via Lysosome Rupture. Oku Y; Murakami K; Irie K; Hoseki J; Sakai Y Cell Struct Funct; 2017 May; 42(1):71-79. PubMed ID: 28413178 [TBL] [Abstract][Full Text] [Related]
7. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. Feng Y; Wang XP; Yang SG; Wang YJ; Zhang X; Du XT; Sun XX; Zhao M; Huang L; Liu RT Neurotoxicology; 2009 Nov; 30(6):986-95. PubMed ID: 19744518 [TBL] [Abstract][Full Text] [Related]
8. Novel antibody against oligomeric amyloid-β: Insight into factors for effectively reducing the aggregation and cytotoxicity of amyloid-β aggregates. Zhang X; Huai Y; Cai J; Song C; Zhang Y Int Immunopharmacol; 2019 Feb; 67():176-185. PubMed ID: 30553911 [TBL] [Abstract][Full Text] [Related]
9. Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly. De Lorenzi E; Chiari M; Colombo R; Cretich M; Sola L; Vanna R; Gagni P; Bisceglia F; Morasso C; Lin JS; Lee M; McGeer PL; Barron AE J Alzheimers Dis; 2017; 59(4):1213-1226. PubMed ID: 28731438 [TBL] [Abstract][Full Text] [Related]
10. Discovery of Neuroregenerative Peptoid from Amphibian Neuropeptide That Inhibits Amyloid-β Toxicity and Crosses Blood-Brain Barrier. Pradhan K; Das G; Gupta V; Mondal P; Barman S; Khan J; Ghosh S ACS Chem Neurosci; 2019 Mar; 10(3):1355-1368. PubMed ID: 30408415 [TBL] [Abstract][Full Text] [Related]
11. Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils. Cui L; Zhang Y; Cao H; Wang Y; Teng T; Ma G; Li Y; Li K; Zhang Y J Alzheimers Dis; 2013; 37(1):19-28. PubMed ID: 23727899 [TBL] [Abstract][Full Text] [Related]
12. Short Peptoid Evolved from the Key Hydrophobic Stretch of Amyloid-β42 Peptide Serves as a Potent Therapeutic Lead of Alzheimer's Disease. Roy R; Khan J; Pradhan K; Nayak P; Sarkar A; Nandi S; Ghosh S; Ram H; Ghosh S ACS Chem Neurosci; 2023 Jan; 14(2):246-260. PubMed ID: 36583718 [TBL] [Abstract][Full Text] [Related]
13. Hydroxylated Single-Walled Carbon Nanotubes Inhibit Aβ Liu F; Wang W; Sang J; Jia L; Lu F ACS Chem Neurosci; 2019 Jan; 10(1):588-598. PubMed ID: 30335950 [TBL] [Abstract][Full Text] [Related]
14. The neuronal S100B protein is a calcium-tuned suppressor of amyloid-β aggregation. Cristóvão JS; Morris VK; Cardoso I; Leal SS; Martínez J; Botelho HM; Göbl C; David R; Kierdorf K; Alemi M; Madl T; Fritz G; Reif B; Gomes CM Sci Adv; 2018 Jun; 4(6):eaaq1702. PubMed ID: 29963623 [TBL] [Abstract][Full Text] [Related]
15. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway. Chang YJ; Chen YR FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730 [TBL] [Abstract][Full Text] [Related]
16. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters. Matsuzaki K Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558 [TBL] [Abstract][Full Text] [Related]
17. Design of LVFFARK and LVFFARK-functionalized nanoparticles for inhibiting amyloid β-protein fibrillation and cytotoxicity. Xiong N; Dong XY; Zheng J; Liu FF; Sun Y ACS Appl Mater Interfaces; 2015 Mar; 7(10):5650-62. PubMed ID: 25700145 [TBL] [Abstract][Full Text] [Related]
18. A mimotope of Aβ oligomers may also behave as a β-sheet inhibitor. Zhang YX; Wang SW; Lu S; Zhang LX; Liu DQ; Ji M; Wang WY; Liu RT FEBS Lett; 2017 Nov; 591(21):3615-3624. PubMed ID: 28976547 [TBL] [Abstract][Full Text] [Related]
19. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage. Ferrera D; Mazzaro N; Canale C; Gasparini L Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of C-Terminal Fragments of Amyloid β-Protein as Aβ Inhibitors: Do C-Terminal Interactions Play a Key Role in Their Inhibitory Activity? Zheng X; Wu C; Liu D; Li H; Bitan G; Shea JE; Bowers MT J Phys Chem B; 2016 Mar; 120(8):1615-23. PubMed ID: 26439281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]